Association between hypovitaminosis D and systemic sclerosis: True or fake?

Clinica Chimica Acta

Volumn 458, Issue , 2016, Pages 115-119

  Bivona, Giulia ^a   Agnello, Luisa ^a   Pivetti, Alessia ^a   Milano, Salvatore ^b   Scazzone, Concetta ^a   Sasso, Bruna Lo ^a   Ciaccio, Marcello ^a,b  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Autoimmunity; Hypovitaminosis D; Systemic Sclerosis; Vitamin D

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; PARATHYROID HORMONE; RETINOIC ACID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR; VITAMIN D;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BONE DENSITY; BONE TURNOVER; CALCIUM BLOOD LEVEL; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; REVIEW; SKIN ABSORPTION; SYSTEMIC SCLEROSIS; T LYMPHOCYTE; UPREGULATION; VITAMIN D DEFICIENCY; BLOOD; GENETICS;

HUMANS; SCLERODERMA, SYSTEMIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84969498445     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.04.026     Document Type: Review

References (53)

1. Wöbke T.K., Sorg B.L., Steinhilber D. Vitamin D in inflammatory diseases. Front. Physiol. 2014, 5:244.
2. Baeke F., Takiishi T., Korf H., Gysemans C., Mathieu C. Vitamin D: modulator of the immune system. Curr. Opin. Pharmacol. 2010, 10(4):482-496.
3. Guillot X., Semerano L., Saidenberg-Kermanac'h N., Falgarone G., Boissier M.C. Vitamin D and inflammation. Joint Bone Spine. 2010, 77(6):552-557.
4. Szodoray P., Nakken B., Gaal J., Jonsson R., Szegedi A., Zold E. The complex role of vitamin D in autoimmune diseases. Scand. J. Immunol. 2008, 68(3):261-269.
5. Yang C.Y., Leung P.S., Adamopoulos I.E., Gershwin M.E. The implication of vitamin D and autoimmunity: a comprehensive review. Clin. Rev. Allergy Immunol. 2013, 45(2):217-226.
6. Agmon-Levin N., Theodor E., Segal R.M., Shoenfeld Y. Vitamin D in systemic and organ-specific autoimmune diseases. Clin. Rev. Allergy Immunol. 2013, 45(2):256-266.
7. Toubi E., Shoenfeld Y. The role of vitamin D in regulating immune responses. Isr. Med. Assoc. J. 2010, 12(3):174-175.
8. Vera-Lastra O.L., Jara L.J. Endocrinological alterations in systemic sclerosis. Reumatol. Clin. 2006, 2(3):S37-S41. 10.1016/S1699-258X(06)73106-0.
9. Corrado A., Colia R., Mele A., Di Bello V., Trotta A., Neve A., et al. Relationship between body mass composition, bone mineral density, skin fibrosis and 25(OH) vitamin D serum levels in systemic sclerosis. PLoS One 2015, 10(9):e0137912. 10.1371.
10. Arnson Y., Amital H., Agmon-Levin N., Alon D., Sánchez-Castañón M., López-Hoyos M. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun. Rev. 2011, 10(8):490-494. 10.1016/j.autrev.2011.02.002.
11. Zhang L., Duan Y., Zhang T.P., Huang X.L., Li B.Z., Ye D.Q. Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study. Int. J. Rheum. Dis. 2015, 10.1111/1756-185X.12794.
12. Atteritano M., Sorbara S., Bagnato G., Miceli G., Sangari D., Morgante S., et al. Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study. PLoS One 2013 Jun 20, 8(6):e66991. 10.1371.
13. Caramaschi P., Dalla Gassa A., Ruzzenente O., Volpe A., Ravagnani V., Tinazzi I., et al. Very low levels of vitamin D in systemic sclerosis patients. Clin. Rheumatol. 2010, 29(12):1419-1425. 10.1007/s10067-010-1478-3.
14. Vacca A., Cormier C., Piras M., Mathieu A., Kahan A., Allanore Y. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J. Rheumatol. 2009, 36(9):1924-1929.
15. Ibn Yacoub Y., Amine B., Laatiris A., Wafki F., Znat F., Hajjaj-Hassouni N. Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatol. Int. 2012 Oct, 32(10):3143-3148.
16. Gambichler T., Chrobok I., Höxtermann S., Kreuter A. Significantly decreased serum 25-hydroxyvitamin d levels in a large german systemic sclerosis cohort. J. Rheumatol. 2011, 38(11):2492-2493. 10.3899/jrheum.110695.
17. Belloli L., Ughi N., Marasini B. Vitamin D in systemic sclerosis. Clin. Rheumatol. 2011, 30(1):145-146. 10.1007/s10067-010-1564-6.
18. Carmel N.N., Rotman-Pikielny P., Lavrov A., Levy Y. Vitamin D antibodies in systemic sclerosis patients: findings and clinical correlations. Isr. Med. Assoc. J. 2015, 17(2):80-84.
19. Carbone L., Tylavsky F., Wan J., McKown K., Cheng S. Bone mineral density in scleroderma. Rheumatology (Oxford) 1999, 37:1-2.
20. Kamen D.L., Cooper G.S., Bouali H., Shaftman S.R., Hollis B.W., Gilkeson G.S. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun. Rev. 2006 Feb, 5(2):114-117.
21. Hollis B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 2005 Feb, 135(2):317-322.
22. Braun-Moscovici Y., Furst D.E., Markovits D., Rozin A., Clements P.J., Nahir A.M., Balbir-Gurman A. Vitamin D, parathyroid hormone, and acroosteolysis in systemic sclerosis. J. Rheumatol. 2008 Nov, 35(11):2201-2205.
23. Braun-Moscovici Y., Toledano K., Markovits D., Rozin A., Nahir A.M., Balbir-Gurman A. Vitamin D level: is it related to disease activity in inflammatory joint disease?. Rheumatol. Int. 2011, 31(4):493-499. 10.1007/s00296-009-1251-6.
24. Kilic G., Kilic E., Akgul O., Ozgocmen S. Increased risk for bone loss in women with systemic sclerosis: a comparative study with rheumatoid arthritis. Int. J. Rheum. Dis. 2013, 28. 10.1111/1756-185X.12242.
25. Calzolari G., Data V., Carignola R., Angeli A. Hypovitaminosis D in systemic sclerosis. J. Rheumatol. 2009, 36(12):2844. 10.3899/jrheum.090439.
26. Rios Fernández R., Fernández Roldán C., Callejas Rubio J.L., Ortego Centeno N. Vitamin D deficiency in a cohort of patients with systemic scleroderma from the south of Spain. J. Rheumatol. 2010, 37(6):1355. 10.3899/jrheum.091143.
27. Zerr P., Vollath S., Palumbo-Zerr K., Tomcik M., Huang J., Distler A. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis. Ann. Rheum. Dis. 2015, 74(3):e20. 10.1136/annrheumdis-2013-204378.
28. Usategui A., Criado G., Del Rey M.J., Faré R., Pablos J.L. Topical vitamin D analogue calcipotriol reduces skin fibrosis in experimental scleroderma. Arch. Dermatol. Res. 2014, 306(8):757-761. 10.1007/s00403-014-1466-6.
29. Abe J., Nakamura K., Takita Y., Nakano T., Irie H., Nishii Y. Prevention of immunological disorders in MRL/l mice by a new synthetic analogue of vitamin D3: 22-oxa-1 alpha,25-dihydroxyvitamin D3. J. Nutr. Sci. Vitaminol. 1990, 36(1):21-31.
30. Larsson P., Mattsson L., Klareskog L., Johnsson C. A vitamin D analogue (MC 1288) has immunomodulatory properties and suppresses collagen-induced arthritis (CIA) without causing hypercalcaemia. Clin. Exp. Immunol. 1998, 114(2):277-283.
31. Cantorna M.T., Yu S., Bruce D. The paradoxical effects of vitamin D on type 1 mediated immunity. Mol. Asp. Med. 2008, 29(6):369-375. 10.1016/j.mam.2008.04.004.
32. Veldman C.M., Cantorna M.T., DeLuca H.F. Expression of 1.25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 2000, 374(2):334-338.
33. Morgan J.W., Kouttab N., Ford D., Maizel A.L. Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology 2000, 141(9):3225-3234.
34. Fernandes de Abreu D.A., Eyles D., Féron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009, 34(1):S265-S277. 10.1016/j.psyneuen.2009.05.023.
35. Ramirez A.M., Wongtrakool C., Welch T., Steinmeyer A., Zügel U., Roman J. Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells. J. Steroid Biochem. Mol. Biol. 2010, 15;118(3):142-150. 10.1016/j.jsbmb.2009.11.004.
36. Waterhouse J.C., Perez T.H., Albert P.J. Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. Ann. N. Y. Acad. Sci. 2009, 1173:757-765. 10.1111/j.1749-6632.2009.04637.x.
37. Bilgin H., Kocabaş H., Keşli R. The prevalence of infectious agents in patients with systemic sclerosis. Turk. J. Med. Sci. 2015, 45(6):1192-1197.
38. Zhou Y.F., Shou M., Harrell R.F., Yu Z.X., Unger E.F., Epstein S.E. Chronic non-vascular cytomegalovirus infection: effects on the neointimal response to experimental vascular injury. Cardiovasc. Res. 2000, 45(4):1019-1025.
39. Tachibana I., Bodorova J., Berditchevski F., Zutter M.M., Hemler M.E. NAG-2, novel transmembrane 4 superfamily (TM4SF) protein that complexes withintegrins and other TM4SF proteins. J. Biol. Chem. 1997, 272(46):29181-29189.
40. Seriolo B., Molfetta L., Cutolo M. Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis. Clin. Rheumatol. 2011, 30(3):445-446. 10.1007/s10067-011-1684-7.
41. Oren Y., Shapira Y., Agmon-Levin N., Kivity S., Zafrir Y., Altman A. Vitamin D insufficiency in a sunny environment: a demographic and seasonal analysis. Isr. Med. Assoc. J. 2010, 12(12):751-756.
42. Ortiz-Santamaria V., Puig C., Soldevilla C., Barata A., Cuquet J., Recasens A. Nutritional support in patients with systemic sclerosis. Reumatol. Clin. 2014, 10(5):283-287. 10.1016/j.reuma.2013.12.011.
43. Antico A., Tampoia M., Tozzoli R., Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun. Rev. 2012, 12(2):127-136. 10.1016/j.autrev.2012.07.007.
44. Terao M., Yang L., Matsumura S., Yutani M., Murota H., Katayama I. A vitamin D analog inhibits Th2 cytokine- and TGFβ-induced periostin production in fibroblasts: a potential role for vitamin D in skin sclerosis. Dermatoendocrinol. 2015, 7(1):e1010983. 10.1080/19381980.2015.1010983.
45. Hegyi Z., Zwicker S., Bureik D., Peric M., Koglin S., Batycka-Baran A. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. J. Investig. Dermatol. 2012, 132(5):1416-1424. 10.1038/jid.2011.486.
46. Lucas R.M., Gorman S., Geldenhuys S., Hart P.H. Vitamin D and immunity. F1000 Prime Rep. 2014, 6(118). 10.12703/P6-118.
47. Pender M.P. CD8+ T-cell deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmun. Dis. 2012, 2012:189096. 10.1155/2012/189096.
48. Zandman-Goddard G., Berkun Y., Barzilai O., Boaz M., Blank M., Ram M., Sherer Y., Anaya J.M., Shoenfeld Y. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann. N. Y. Acad. Sci. 2009, 1173:658-663. 10.1111/j.1749-6632.2009.04754.x.
49. Zakrzewska K., Corcioli F., Carlsen K.M., Giuggioli D., Fanci R., Rinieri A., Ferri C., Azzi A. Human parvovirus B19 (B19V) infection in systemic sclerosis patients. Intervirology 2009, 52(5):279-282. 10.1159/000232945.
50. Ferri C., Cazzato M., Giuggioli D., Sebastiani M., Magro C. Systemic sclerosis following human cytomegalovirus infection. Ann. Rheum. Dis. 2002, 61(10):937-938.
51. Randone S.B., Guiducci S., Cerinic M.M. Systemic sclerosis and infections. Autoimmun. Rev. 2008, 8(1):36-40. 10.1016/j.autrev.2008.07.022.
52. Mendall M.A., Goggin P.M., Molineaux N., Levy J., Toosy T., Strachan D., Camm A.J., Northfield T.C. Relation of Helicobacter pylori infection and coronary heart disease. Br. Heart J. 1994 May, 71(5):437-439.
53. Kalabay L., Fekete B., Czirják L., Horváth L., Daha M.R., Veres A., Fónyad G., Horváth A., Viczián A., Singh M., Hoffer I., Füst G., Romics L., Prohászka Z. Helicobacter pylori infection in connective tissue disorders is associated with high levels ofantibodies to mycobacterial hsp65 but not to human hsp60. Helicobacter 2002, 7(4):250-256.